BioSpace News Archive

rope that is about to break, with eerie background

Opinion

Opinion: Prasad’s FDA exit good for rare diseases but new CBER head must repair eroded trust

The FDA is signaling change, but actual success depends on more than simply bringing in a new leader at the Center for Biologics Evaluation and Research; it requires accountability, transparency and consistent action.

April 24, 2026

·

5 min read

·

Joshua R. Mansbach

Stack of coins balancing on seesaw over a bottle of pills.

Drug pricing

Regeneron finally joins Trump’s drug pricing push while notching landmark approval

Of the 17 companies that were implored by the White House last July to apply Most Favored Nation pricing to their drugs, Regeneron is the last to agree—the same day the FDA greenlit its gene therapy for hearing loss in kids.

April 24, 2026

·

2 min read

·

Tristan Manalac

Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.

Earnings

Daiichi Sankyo shares slip after delaying annual earnings report

Daiichi Sankyo’s full-year report was originally scheduled for April 27 but has now been pushed back to May 11. That same day, the pharma expects to release its five-year business plan.

April 24, 2026

·

2 min read

·

Tristan Manalac

Dashed line from pills isolated on white

Pipeline

Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer

Pfizer’s decision to cut its early-stage cancer asset was due to “strategic business reasons” and not driven by safety or efficacy concerns.

April 24, 2026

·

2 min read

·

Tristan Manalac

Psychedelics

FDA awards priority vouchers to 3 undisclosed companies for investigational psychedelics

While the FDA did not announce the recipient names of the Commissioner’s National Priority Vouchers, the agency’s descriptions of the awarded products match those in development at Compass Pathways, Transcend Therapeutics and Usona Institute.

April 24, 2026

·

3 min read

·

Heather McKenzie

Journalism. Camera and photos. Mass media, television, interview, breaking news, press conference concept. Flat vector

Editorial

BioSpace elevates journalism as biopharma evolves in the Trump era

Neal and Azbee awards have validated our approach to reporting on the industry at a time of unprecedented shifts at the FDA and other federal agencies.

April 24, 2026

·

4 min read

·

Jef Akst

Press Releases

IMAAVY® (nipocalimab)▼shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

April 24, 2026

·

17 min read

Press Releases

PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses